Cancer Drug Loss

Summary


A DRUG company has lost its appeal to get a Tynesidedeveloped treatment extended to lung cancer patients.

The National Institute for Health and Clinical Excellence (Nice) last month accepted Alimta for treating people with asbestos- related cancer on the NHS.

See the full content of this document

Extract


Cancer Drug Loss

Following an a...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United Kingdom

Explore vLex

For Professionals

For Partners

Company